These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15821276)

  • 1. Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium.
    Lee TY; Chen CM; Lee CN; Chiang YC; Chen HY
    Am J Health Syst Pharm; 2005 Apr; 62(8):828-33. PubMed ID: 15821276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
    Akapo S; Gupta J; Martinez E; McCrea C; Ye L; Roach M
    Ann Pharmacother; 2008 Oct; 42(10):1416-24. PubMed ID: 18780805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respimat (a new soft mist inhaler) delivering fenoterol plus ipratropium bromide provides equivalent bronchodilation at half the cumulative dose compared with a conventional metered dose inhaler in asthmatic patients.
    Kunkel G; Magnussen H; Bergmann K; Juergens UR; de Mey C; Freund E; Hinzmann R; Beckers B
    Respiration; 2000; 67(3):306-14. PubMed ID: 10867600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalation solutions: which one are allowed to be mixed? Physico-chemical compatibility of drug solutions in nebulizers.
    Kamin W; Schwabe A; Krämer I
    J Cyst Fibros; 2006 Dec; 5(4):205-13. PubMed ID: 16678502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic equivalence of a fenoterol/ipratropium bromide combination (Berodual) inhaled as a dry powder and by metered dose inhaler in chronic obstructive airway disease.
    Rammeloo RH; Luursema PB; Sips AP; Beumer HM; Wald FD; Cornelissen PJ
    Respiration; 1992; 59(6):322-6. PubMed ID: 1488568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osmolality and pH of anti-asthmatic drug solutions.
    Desager KN; Van Bever HP; Stevens WJ
    Agents Actions; 1990 Nov; 31(3-4):225-8. PubMed ID: 2150739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled fenoterol-ipratropium bromide in mechanically ventilated patients with chronic obstructive pulmonary disease.
    Guerin C; Chevre A; Dessirier P; Poncet T; Becquemin MH; Dequin PF; Le Guellec C; Jacques D; Fournier G
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1036-42. PubMed ID: 10194143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fenoterol-ipratropium nebulization in infants with obstructive bronchial syndrome].
    Calvo M; Grob K; Herrmann M; Marín F
    Rev Chil Pediatr; 1990; 61(4):193-7. PubMed ID: 2150891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicochemical compatibility of fluticasone-17- propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions.
    Kamin W; Schwabe A; Krämer I
    Int J Chron Obstruct Pulmon Dis; 2007; 2(4):599-607. PubMed ID: 18268934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of ipratropium bromide and fenoterol administered by metered-dose inhaler and aerosolized solution.
    Marlin GE
    Respiration; 1986; 50 Suppl 2():290-3. PubMed ID: 2951824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osmolality changes in nebulizer solutions.
    Schöni MH; Kraemer R
    Eur Respir J; 1989 Oct; 2(9):887-92. PubMed ID: 2572453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchodilator action of inhaled fenoterol and ipratropium in normal subjects: a teaching exercise for medical students.
    Taylor RG; Maclagan J; Cook DG
    Br J Clin Pharmacol; 1989 Dec; 28(6):709-13. PubMed ID: 2532922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchodilator response to inhaled beta-2 agonist and anticholinergic drugs in patients with bronchiectasis.
    Hassan JA; Saadiah S; Roslan H; Zainudin BM
    Respirology; 1999 Dec; 4(4):423-6. PubMed ID: 10612580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative efficacy of single Berodual inhalation in patients with bronchial asthma: nebulization against dose-adjusted aerosol].
    Tsoí AN; Shor OA; Kepanova EB
    Klin Med (Mosk); 1997; 75(8):51-5. PubMed ID: 9340441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxitropium bromide (Ba 253), an advance in the field of anticholinergic bronchodilating treatments. Preliminary results.
    Minette A; Marcq M
    Rev Inst Hyg Mines (Hasselt); 1979; 34(3):115-23. PubMed ID: 45210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individual results of treatment of COPD with low doses of fenoterol compared with treatment with ipratropium bromide.
    Hodzhev B; Kostianev S; Todorov I; Belev G; Kartev S
    Folia Med (Plovdiv); 1999; 41(4):46-52. PubMed ID: 10786204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic assay for the simultaneous determination of ipratropium bromide, fenoterol, salbutamol and terbutaline in nebulizer solution.
    Jacobson GA; Peterson GM
    J Pharm Biomed Anal; 1994 Jun; 12(6):825-32. PubMed ID: 7918785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium, or acetylcysteine sodium.
    Bonasia PJ; McVicar WK; Bill W; Ong S
    Respir Care; 2008 Dec; 53(12):1716-22. PubMed ID: 19025708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of ipratropium bromide and fenoterol nebulizer solutions in children with asthma.
    Freeman J; Landau LI
    Clin Pediatr (Phila); 1989 Dec; 28(12):556-60. PubMed ID: 2531051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nebuliser delivery of berodual in patients with bronchial asthma and chronic obstructive bronchitis].
    Iakushin SS; Smirnova EA
    Klin Med (Mosk); 1999; 77(7):49. PubMed ID: 10483167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.